Throwing new light on lung cancer pathogenesis: Updates on three recent topics

被引:15
作者
Tomida, S
Yatabe, Y
Yanagisawa, K
Mitsudomi, T
Takahashi, T [1 ]
机构
[1] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Aichi, Japan
[2] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Aichi, Japan
[3] Aichi Canc Ctr Hosp, Dept Thorac Surg, Aichi, Japan
[4] Nagoya Univ, Grad Sch Med, Ctr Neural Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi, Japan
关键词
D O I
10.1111/j.1349-7006.2005.00021.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancers have become the leading cause of cancer deaths in Japan, claiming more than 55 000 lives annually. Unfortunately, substantial improvement in terms of cure rates has not been achieved over the last two decades, although during the same period of time in-depth basic knowledge of the molecular mechanisms, which underlies carcinogenesis and progression of this deadly group of neoplasms, has accumulated at an amazing pace. it has consequently become evident that they have many shared but also distinct features, when comparisons are made not only with other common epithelial cancers of adults, such as colon cancer, but also within the various histologic types of lung cancers themselves. This review article provides an up-date on cutting-edge research into the following three different topics, from which important new insights have been obtained. The first concerns genetic instability, especially chromosome instability, and checkpoint failure in lung cancers. Second, we deal with EGFR mutations, which shows revealing specificities in various aspects. Finally, advances in the expression profiling analysis of both transcriptomes and proteomes of lung cancers are summarized.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 56 条
[1]   Chromosomal imbalances in human lung cancer [J].
Balsara, BR ;
Testa, JR .
ONCOGENE, 2002, 21 (45) :6877-6883
[2]   Gene-expression profiles predict survival of patients with lung adenocarcinoma [J].
Beer, DG ;
Kardia, SLR ;
Huang, CC ;
Giordano, TJ ;
Levin, AM ;
Misek, DE ;
Lin, L ;
Chen, GA ;
Gharib, TG ;
Thomas, DG ;
Lizyness, ML ;
Kuick, R ;
Hayasaka, S ;
Taylor, JMG ;
Iannettoni, MD ;
Orringer, MB ;
Hanash, S .
NATURE MEDICINE, 2002, 8 (08) :816-824
[3]   Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].
Bhattacharjee, A ;
Richards, WG ;
Staunton, J ;
Li, C ;
Monti, S ;
Vasa, P ;
Ladd, C ;
Beheshti, J ;
Bueno, R ;
Gillette, M ;
Loda, M ;
Weber, G ;
Mark, EJ ;
Lander, ES ;
Wong, W ;
Johnson, BE ;
Golub, TR ;
Sugarbaker, DJ ;
Meyerson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795
[4]   Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways [J].
Borczuk, AC ;
Gorenstein, L ;
Walter, KL ;
Assaad, AA ;
Wang, LQ ;
Powell, CA .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) :1949-1960
[5]  
Brose MS, 2002, CANCER RES, V62, P6997
[6]  
Campa MJ, 2003, CANCER RES, V63, P1652
[7]   Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer [J].
Cappuzzo, F ;
Magrini, E ;
Ceresoli, GL ;
Bartolini, S ;
Rossi, E ;
Ludovini, V ;
Gregorc, V ;
Ligorio, C ;
Cancellieri, A ;
Damiani, S ;
Spreafico, A ;
Paties, CT ;
Lombardo, L ;
Calandri, C ;
Bellezza, G ;
Tonato, M ;
Crinò, L .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) :1133-1141
[8]   The human decatenation checkpoint [J].
Deming, PB ;
Cistulli, CA ;
Zhao, H ;
Graves, PR ;
Piwnica-Worms, H ;
Paules, RS ;
Downes, CS ;
Kaufmann, WK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :12044-12049
[9]   Cell cycle checkpoints: Preventing an identity crisis [J].
Elledge, SJ .
SCIENCE, 1996, 274 (5293) :1664-1672
[10]   Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction [J].
Endoh, H ;
Tomida, S ;
Yatabe, Y ;
Konishi, H ;
Osada, H ;
Tajima, K ;
Kuwano, T ;
Takahashi, T ;
Mitsudomi, T .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :811-819